Krystal Biotech, Inc. Research And Development Expense

• Krystal Biotech, Inc. showed an increase of +8.3% in Research And Development Expense from 2024 to 2025.
• This data is from Krystal Biotech, Inc.'s annual report (Form 10-K), filed with the SEC on February 17, 2026.
• XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 10 years of available data (2016 to 2025), Krystal Biotech, Inc.'s Research And Development Expense has grown by 7,733.3%.
• Historical annual values: Fiscal year 2025: $58.05 million | Fiscal year 2024: $53.58 million | Fiscal year 2023: $46.43 million | Fiscal year 2022: $42.46 million | Fiscal year 2021: $27.88 million | Fiscal year 2020: $17.94 million | Fiscal year 2019: $15.62 million | Fiscal year 2018: $7.76 million | Fiscal year 2017: $3.21 million | Fiscal year 2016: $741.0 thousand.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026